Neonatal screening for congenital adrenal hyperplasia in taiwan: A pilot study

Journal of the Formosan Medical Association

Volumn 101, Issue 10, 2002, Pages 691-694

  Chu, Shao Yin ^b   Tsai, Wen Yu ^a   Chen, Li Hsin ^a   Wei, Ming Lee ^a   Chien, Yin Hsiu ^a   Hwu, Wuh Liang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Congenital adrenal hyperplasia; Neonatal screening; Taiwan

Indexed keywords

HYDROXYPROGESTERONE; SODIUM CHLORIDE;

ADRENAL CORTEX INSUFFICIENCY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLOOD ANALYSIS; CAPILLARY BLOOD; CHILD HEALTH CARE; CHILDBIRTH; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; PHENOTYPE; PILOT STUDY; PREVALENCE; QUANTITATIVE ANALYSIS; SALT LOSING NEPHRITIS; STEROIDOGENESIS; TAIWAN; VIRILIZATION;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PILOT PROJECTS;

EID: 0036819011     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Pang S, Murphey W, Levine LS, et al: A pilot newborn screening program for congenital adrenal hyperplasia in Alaska. J clin Endocrinol Metab 1982;55:413-20.
2. Pang S, Shook MK: Current status of neonatal screening for congenital adrenal hyperplasia. Curr Opin Pediatr 1997;9:419-23.
3. Pang S, Wallace MA, Hofman L, et al: Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81:866-74.
4. Cicognani A: The experience of neonatal screening for congenital adrenal hyperplasia. Horm Res 1992;37(Suppl 3):34-8.
5. Shimozawa K, Saisho S, Saito N, et al: A neonatal mass-screening for congenital adrenal hyperplasia in Japan. Acta Endocrinol 1984;107:513-8.
6. Thil'en A, Nordenstrom A, Hagenfeldt L, et al: Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics 1998; 101:694.
7. Lebovitz RM, Pauli RM, Laxova R: Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening. Am J Dis Child 1984;138:571-3.
8. Kandemir N, Yordam N: Congenital adrenal hyperplasia in Turkey: a review of 273 patients. Acta Paediatr 1997;86:22-5.
9. Lee HH, Hou JM, Chao HT, et al: Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese. J Clin Endocrinol Metab 2000;85:597-600.
10. Brosnan PG, Brosnan CA, Kemp AF, et al: Effect of newborn screening for congenital adrenal hyperplasia. Arch Pediatr Adolesc Med 1999;153:1272-8.
11. Ko TM, Kao CH, Ho HN, et al: Congenital adrenal hyperplasia. Molecular characterization. J Reprod Med 1998;43:379-86.
12. Al Saedi S, Dean H, Dent W, et al: Screening for congenital adrenal hryperplasia: the delfia screening test overestimates serum 17-hydroxyprogesterone in preterm infants. Pediatric 1996;97:100-2.
13. Lange-Kubini K, Zachmann M, Kempken B, et al: 15-Beta hydroxylated steroids may be diagnostically misleading in confirming congenital adrenal hyperplasia suspected by a newborn screening program. Eur J Pediatr 1996;155: 923-31.
14. Al Saedi S, Dean H, Dent W, et al: Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants. J Pediatr 1995;126:985-7.
15. Allen DB, Hoffman GL, Fitzpatrick P, et al: Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels, J Pediatr 1997;130:128-33.
16. Lee SS, Chao HT, Lee YJ, et al: Identification of four novel mutations in the CYP21 gene in congenital adrenal hyperplasia in the Chinese. Hum Genet 1998;103:304-10.
17. Nordenstrom A, Thilen A, Hagenfeldt A, et al: Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84:1505-9.
18. Lajic S, Levo A, Nikoshkov A, et al: A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction. Hum Genet 1997; 99:704-9.
19. Nikoshkov A, Lajic S, Vlamis-Gardikas A, et al: Naturally occuring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability. J Biol Chem 1998;273:6163-5.
20. Root AW: Neonatal screening for 21-hydroxylase deficient congenital adrenal hyperplasia - the role of CYP21 analysis. J Clin Endocrinol Metab 1999;84:1503-4.